Cargando…
Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma
Thrombosis and bleeding are significant contributors to morbidity and mortality in patients with hematological cancer, and the impact of altered fibrinolysis on bleeding and thrombosis risk is poorly understood. In this prospective cohort study, we investigated the dynamics of fibrinolysis in patien...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694522/ https://www.ncbi.nlm.nih.gov/pubmed/37756519 http://dx.doi.org/10.1182/bloodadvances.2023011379 |